GT Biopharma, Inc.
GTBP· Nasdaq
GTBPGT Biopharma, Inc.
Filed Nov 18, 2014 · 10-K · 687 days after period end · 0001513160-14-000064
derived · Computed from the longer spans the company filed.
| Metric | Q4 2012dderived from reported figures | Q4 2011dderived from reported figures | Q4 2010dderived from reported figures |
|---|---|---|---|
| Revenue | $220.00K | $3.00K | — |
| Net Income | -$761.00K | -$1.14M | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
GT Biopharma, Inc. · CIK 109657 · Engraved from SEC EDGAR
ended Dec 31, 2012 · filed Nov 18, 2014 · 687 d after period end
